Does RIBOFLAVIN 5^-PHOSPHATE Cause Therapy cessation? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Therapy cessation have been filed in association with RIBOFLAVIN 5^-PHOSPHATE. This represents 12.3% of all adverse event reports for RIBOFLAVIN 5^-PHOSPHATE.
30
Reports of Therapy cessation with RIBOFLAVIN 5^-PHOSPHATE
12.3%
of all RIBOFLAVIN 5^-PHOSPHATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy cessation From RIBOFLAVIN 5^-PHOSPHATE?
Of the 30 reports.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN 5^-PHOSPHATE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN 5^-PHOSPHATE Cause?
Eye pain (53)
Visual impairment (44)
Corneal opacity (40)
No adverse event (38)
Drug ineffective (26)
Corneal infiltrates (25)
Corneal scar (22)
Device issue (20)
Incorrect product administration duration (17)
Product use issue (16)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which RIBOFLAVIN 5^-PHOSPHATE Alternatives Have Lower Therapy cessation Risk?
RIBOFLAVIN 5^-PHOSPHATE vs RIFABUTIN
RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPICIN
RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPIN
RIBOFLAVIN 5^-PHOSPHATE vs RIFAMYCIN
RIBOFLAVIN 5^-PHOSPHATE vs RIFAPENTINE